COIN vs CRVS · P/E 64, rev $2.63B vs $1.04B cap
Coinbase Global Inc (COIN) versus Corvus Pharmaceuticals Inc (CRVS) — a side-by-side from cached financials, not a winner call.
Coinbase Global Inc (COIN) is a financial data & stock exchanges company listed on US. It is led by Brian Armstrong.
Corvus Pharmaceuticals Inc (CRVS) is a biotechnology company listed on US.
Latest reported COIN revenue for 2026-06-30 was $2.63B. Net income was -$753.6M. Revenue was up 86.3% from 2026-03-31 to 2026-06-30. COIN currently screens at market cap $45.84B and trailing P/E 64.2.
CRVS does not have a complete income-statement cache yet.
COIN currently screens at market cap $45.84B and trailing P/E 64.2. CRVS currently screens at market cap $1.04B.
Not investment advice. Open the COIN and CRVS stock pages for the full models.
Not investment advice.